Clinical Trial Update: Probiotic BIO-25 as a Supplement to Statins for the Treatment of Hypercholesterolemia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for BIO-25 probiotic as a supplement to statins in hypercholesterolemia; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• BIO-25

Snippet

Sponsor: Meir Medical Center | Conditions: Hypercholesterolemia | Phase 4 | Status: UNKNOWN